These compounds may interact with:

Inhibitor of nuclear factor kappa-B kinase subunit alpha

Potentially involved in: kidney cancer; carcinoma; type 2 diabetes mellitus; cocoon syndrome; chromosome 1q21.1 deletion syndrome; popliteal pterygium syndrome; cancer; bone diseases, developmental; cleft palate; fetal diseases; skin abnormalities; limb deformities, congenital; protrusion of tongue; hypoplasia of lower limb; thin skin; small head; congenital absence of jaw; congenital absence of mandible; congenital absence of external ear; congenital omphalocele

Disease data sourced from Pharos.